Review



recombinant vegfb  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress recombinant vegfb
    Recombinant Vegfb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+vegfb/VEGF-B%2C+Human/pm41956242-309-6-8
    Average 94 stars, based on 1 article reviews
    recombinant vegfb - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: High throughput screening identifies sanguinarine chloride as a multi-faceted therapeutic agent for PRCC-TFE3 rRCC by targeting lactylation-driven VEGFB-VEGFR2 signaling and PMN-MDSC infiltration.
    Article Snippet: For pharmacological inhibition of lactate production, 10 lM RS6212 (MCE, HY-150753) or 10 mM 2-DG (MCE, HY-13966) were used to treat UOK120 for 24 h. Exogenous lactate (Sigma, 1614308) was supplemented at final concentrations of 5, 10, or 20 mM for 24 h. 600 lM AZD3965 (MCE, HY-12750) was used to treat UOK120 for 24 h, to inhibit MCT1. .. VEGFR2 was stimulated with 2 lg/mL recombinant VEGFB (MCE, HY-P72431) for 24 h, STAT3 was activated by 20 ng/mL IL-6 (MCE, HY-P7044). .. Nacetylcysteine (NAC, MCE, HY-B0215), a reactive oxygen species inhibitor (ROS inhibitor), was used to treat UOK120 cells at 5 mM for 24 h.



    Similar Products

    86
    Novoprotein recombinant human vegfb
    Recombinant Human Vegfb, supplied by Novoprotein, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+vegfb/human+mouse+recombinant+vegfa/pm42286273-39-17-20
    Average 86 stars, based on 1 article reviews
    recombinant human vegfb - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    MedChemExpress recombinant vegfb
    Recombinant Vegfb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+vegfb/VEGF-B%2C+Human/pm41956242-309-6-8
    Average 94 stars, based on 1 article reviews
    recombinant vegfb - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    91
    Novus Biologicals recombinant mouse vegfb 186
    Recombinant Mouse Vegfb 186, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+vegfb/Recombinant+Mouse+PDGFA+Protein/pm36635563-783-58-62
    Average 91 stars, based on 1 article reviews
    recombinant mouse vegfb 186 - by Bioz Stars, 2026-11
    91/100 stars
      Buy from Supplier

    93
    R&D Systems vegfb
    Vegfb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+vegfb/Recombinant+Mouse+VEGF-B+186+Protein/pm36632459-81-10-16
    Average 93 stars, based on 1 article reviews
    vegfb - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human vegfb 167
    Recombinant Human Vegfb 167, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+vegfb/Recombinant+Human+VEGF-B+167+Protein%2C+CF/pmc10197948-79-10-16
    Average 93 stars, based on 1 article reviews
    recombinant human vegfb 167 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    R&D Systems vegfb 167
    Vegfb 167, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+vegfb/Recombinant+Mouse+VEGF-B+167+Protein/pmc08727311-53-17-29
    Average 93 stars, based on 1 article reviews
    vegfb 167 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    97
    R&D Systems recombinant mouse vegfb protein
    <t>VEGFB</t> promoted the proliferation of C2C12 cells via VEGFRs signaling. ( A ) Effect of 100 ng/mL of VEGFB and/or 2 µM of axitinib on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( B ) Effects of 100 ng/mL of VEGFB and/or 2 µM of axitinib on C2C12 proliferation were assessed by using EdU incorporation assay, with the EdU-positive nuclei shown in green. The nuclei were stained with Hoechst, and the scale bar = 200 µm ( n = 3). ( C ) Percentage of EdU-positive cells in panel B. ( D ) Western blot of PCNA and cyclin D1 in C2C12 after 48 h culture. GAPDH was used as loading control. ( E ) Mean ± SEM of immunoblotting bands of PCNA and cyclin D1; the results are expressed as arbitrary units ( n = 6). * p < 0.05 versus control group. n.s = not significant.
    Recombinant Mouse Vegfb Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+vegfb/Recombinant+Human+VEGF+165+Protein/pmc08707860-123-0-8
    Average 97 stars, based on 1 article reviews
    recombinant mouse vegfb protein - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    90
    PeproTech human recombinant vegfb
    <t>VEGFB</t> promoted the proliferation of C2C12 cells via VEGFRs signaling. ( A ) Effect of 100 ng/mL of VEGFB and/or 2 µM of axitinib on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( B ) Effects of 100 ng/mL of VEGFB and/or 2 µM of axitinib on C2C12 proliferation were assessed by using EdU incorporation assay, with the EdU-positive nuclei shown in green. The nuclei were stained with Hoechst, and the scale bar = 200 µm ( n = 3). ( C ) Percentage of EdU-positive cells in panel B. ( D ) Western blot of PCNA and cyclin D1 in C2C12 after 48 h culture. GAPDH was used as loading control. ( E ) Mean ± SEM of immunoblotting bands of PCNA and cyclin D1; the results are expressed as arbitrary units ( n = 6). * p < 0.05 versus control group. n.s = not significant.
    Human Recombinant Vegfb, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+vegfb/human+recombinant+vegfb/pm32302573-580-39-41
    Average 90 stars, based on 1 article reviews
    human recombinant vegfb - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    93
    Bio-Techne corporation recombinant human vegf-b 167 protein, cf
    <t>VEGFB</t> promoted the proliferation of C2C12 cells via VEGFRs signaling. ( A ) Effect of 100 ng/mL of VEGFB and/or 2 µM of axitinib on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( B ) Effects of 100 ng/mL of VEGFB and/or 2 µM of axitinib on C2C12 proliferation were assessed by using EdU incorporation assay, with the EdU-positive nuclei shown in green. The nuclei were stained with Hoechst, and the scale bar = 200 µm ( n = 3). ( C ) Percentage of EdU-positive cells in panel B. ( D ) Western blot of PCNA and cyclin D1 in C2C12 after 48 h culture. GAPDH was used as loading control. ( E ) Mean ± SEM of immunoblotting bands of PCNA and cyclin D1; the results are expressed as arbitrary units ( n = 6). * p < 0.05 versus control group. n.s = not significant.
    Recombinant Human Vegf B 167 Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+vegfb/Recombinant+Human+VEGF-B+167+Protein%2C+CF/bio-techne+corporation___751-veb
    Average 93 stars, based on 1 article reviews
    recombinant human vegf-b 167 protein, cf - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    VEGFB promoted the proliferation of C2C12 cells via VEGFRs signaling. ( A ) Effect of 100 ng/mL of VEGFB and/or 2 µM of axitinib on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( B ) Effects of 100 ng/mL of VEGFB and/or 2 µM of axitinib on C2C12 proliferation were assessed by using EdU incorporation assay, with the EdU-positive nuclei shown in green. The nuclei were stained with Hoechst, and the scale bar = 200 µm ( n = 3). ( C ) Percentage of EdU-positive cells in panel B. ( D ) Western blot of PCNA and cyclin D1 in C2C12 after 48 h culture. GAPDH was used as loading control. ( E ) Mean ± SEM of immunoblotting bands of PCNA and cyclin D1; the results are expressed as arbitrary units ( n = 6). * p < 0.05 versus control group. n.s = not significant.

    Journal: International Journal of Molecular Sciences

    Article Title: VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway

    doi: 10.3390/ijms222413352

    Figure Lengend Snippet: VEGFB promoted the proliferation of C2C12 cells via VEGFRs signaling. ( A ) Effect of 100 ng/mL of VEGFB and/or 2 µM of axitinib on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( B ) Effects of 100 ng/mL of VEGFB and/or 2 µM of axitinib on C2C12 proliferation were assessed by using EdU incorporation assay, with the EdU-positive nuclei shown in green. The nuclei were stained with Hoechst, and the scale bar = 200 µm ( n = 3). ( C ) Percentage of EdU-positive cells in panel B. ( D ) Western blot of PCNA and cyclin D1 in C2C12 after 48 h culture. GAPDH was used as loading control. ( E ) Mean ± SEM of immunoblotting bands of PCNA and cyclin D1; the results are expressed as arbitrary units ( n = 6). * p < 0.05 versus control group. n.s = not significant.

    Article Snippet: Recombinant mouse VEGFB protein (#293-VE-010) was purchased from R&D systems (Minneapolis, MN, USA).

    Techniques: Staining, Western Blot, Control

    Knockdown of VEGFR1, but not NRP1, eliminated the promotion of C2C12 proliferation induced by VEGFB. ( A ) Western blot of VEGFR1 and NRP1 in C2C12 after 48 h culture. GAPDH was used as loading control. ( B ) Mean ± SEM of immunoblotting bands of VEGFR1 and NRP1; the results are expressed as arbitrary units ( n = 6). ( C ) Effect of 100 ng/mL of VEGFB and/or siVEGFR1 on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( D ) Effects of 100 ng/mL of VEGFB and/or siVEGFR1 on C2C12 proliferation were assessed by using EdU incorporation assay ( n = 3). The nuclei were stained with Hoechst. Scale bar = 200 µm. ( E ) Percentage of EdU-positive cells in panel D. ( F ) Western blot analysis of PCNA and cyclin D1 in C2C12 after 48 h culture. β-Tubulin was used as loading control. ( G ) Mean ± SEM of immunoblotting bands of PCNA and cyclin D1; the results are expressed as arbitrary units ( n = 3). ( H ) Effect of 100 ng/mL of VEGFB and/or siNRP1 on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( I ) Effects of 100 ng/mL of VEGFB and/or siNRP1 on C2C12 proliferation by using EdU incorporation assay ( n = 3). The nuclei were stained with Hoechst. Scale bar = 200 µm. ( J ) Percentage of EdU-positive cells in panel H. * p < 0.05 versus control group. # p < 0.05 versus the siNRP1 group. n.s = not significant. siVEGFR1 and siNRP1, small interfering RNA for VEGFR1 and NRP1, respectively.

    Journal: International Journal of Molecular Sciences

    Article Title: VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway

    doi: 10.3390/ijms222413352

    Figure Lengend Snippet: Knockdown of VEGFR1, but not NRP1, eliminated the promotion of C2C12 proliferation induced by VEGFB. ( A ) Western blot of VEGFR1 and NRP1 in C2C12 after 48 h culture. GAPDH was used as loading control. ( B ) Mean ± SEM of immunoblotting bands of VEGFR1 and NRP1; the results are expressed as arbitrary units ( n = 6). ( C ) Effect of 100 ng/mL of VEGFB and/or siVEGFR1 on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( D ) Effects of 100 ng/mL of VEGFB and/or siVEGFR1 on C2C12 proliferation were assessed by using EdU incorporation assay ( n = 3). The nuclei were stained with Hoechst. Scale bar = 200 µm. ( E ) Percentage of EdU-positive cells in panel D. ( F ) Western blot analysis of PCNA and cyclin D1 in C2C12 after 48 h culture. β-Tubulin was used as loading control. ( G ) Mean ± SEM of immunoblotting bands of PCNA and cyclin D1; the results are expressed as arbitrary units ( n = 3). ( H ) Effect of 100 ng/mL of VEGFB and/or siNRP1 on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( I ) Effects of 100 ng/mL of VEGFB and/or siNRP1 on C2C12 proliferation by using EdU incorporation assay ( n = 3). The nuclei were stained with Hoechst. Scale bar = 200 µm. ( J ) Percentage of EdU-positive cells in panel H. * p < 0.05 versus control group. # p < 0.05 versus the siNRP1 group. n.s = not significant. siVEGFR1 and siNRP1, small interfering RNA for VEGFR1 and NRP1, respectively.

    Article Snippet: Recombinant mouse VEGFB protein (#293-VE-010) was purchased from R&D systems (Minneapolis, MN, USA).

    Techniques: Knockdown, Western Blot, Control, Staining, Small Interfering RNA

    VEGFB activated the PI3K/Akt signaling pathway in a VEGFR1-dependent manner, and the inhibition of PI3K/Akt blocked the promotion of C2C12 proliferation induced by VEGFB. ( A ) Western blot analysis of p-PI3K, PI3K, p-Akt, and Akt in C2C12 after 48 h culture. GAPDH was used as loading control. ( B ) Mean ± SEM of immunoblotting bands of p-PI3K, PI3K, p-Akt, and Akt in panel A ( n = 3). ( C ) Western blot of p-PI3K, PI3K, p-Akt, and Akt in C2C12 after 48 h culture. β-Tubulin was used as loading control. ( D ) Mean ± SEM of immunoblotting bands of p-PI3K, PI3K, p-Akt, and Akt in panel C; the results are expressed as arbitrary units ( n = 3). ( E ) Effect of 100 ng/mL of VEGFB and/or 2 µM of Wortmannin on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( F ) Effects of 100 ng/mL of VEGFB and/or 2 µM of Wortmannin on C2C12 proliferation were assessed by using EdU incorporation assay (n = 3). The nuclei were stained with Hoechst, and the scale bar = 200 µm. ( G ) Percentage of EdU-positive cells in panel F. ( H ) Western blot analysis of PCNA, cyclin D1, p-PI3K, PI3K, p-Akt, and Akt in C2C12 after 48 h culture. GAPDH was used as loading control. ( I ) Mean ± SEM of immunoblotting bands of PCNA, cyclin D1, p-PI3K, PI3K, p-Akt, and Akt; the results are expressed as arbitrary units ( n = 3). * p < 0.05 versus control group. n.s = not significant. siVEGFR1, small interfering RNA for VEGFR1.

    Journal: International Journal of Molecular Sciences

    Article Title: VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway

    doi: 10.3390/ijms222413352

    Figure Lengend Snippet: VEGFB activated the PI3K/Akt signaling pathway in a VEGFR1-dependent manner, and the inhibition of PI3K/Akt blocked the promotion of C2C12 proliferation induced by VEGFB. ( A ) Western blot analysis of p-PI3K, PI3K, p-Akt, and Akt in C2C12 after 48 h culture. GAPDH was used as loading control. ( B ) Mean ± SEM of immunoblotting bands of p-PI3K, PI3K, p-Akt, and Akt in panel A ( n = 3). ( C ) Western blot of p-PI3K, PI3K, p-Akt, and Akt in C2C12 after 48 h culture. β-Tubulin was used as loading control. ( D ) Mean ± SEM of immunoblotting bands of p-PI3K, PI3K, p-Akt, and Akt in panel C; the results are expressed as arbitrary units ( n = 3). ( E ) Effect of 100 ng/mL of VEGFB and/or 2 µM of Wortmannin on the proliferation of C2C12 after 48 h culture was determined by CCK8 analysis ( n = 6). ( F ) Effects of 100 ng/mL of VEGFB and/or 2 µM of Wortmannin on C2C12 proliferation were assessed by using EdU incorporation assay (n = 3). The nuclei were stained with Hoechst, and the scale bar = 200 µm. ( G ) Percentage of EdU-positive cells in panel F. ( H ) Western blot analysis of PCNA, cyclin D1, p-PI3K, PI3K, p-Akt, and Akt in C2C12 after 48 h culture. GAPDH was used as loading control. ( I ) Mean ± SEM of immunoblotting bands of PCNA, cyclin D1, p-PI3K, PI3K, p-Akt, and Akt; the results are expressed as arbitrary units ( n = 3). * p < 0.05 versus control group. n.s = not significant. siVEGFR1, small interfering RNA for VEGFR1.

    Article Snippet: Recombinant mouse VEGFB protein (#293-VE-010) was purchased from R&D systems (Minneapolis, MN, USA).

    Techniques: Inhibition, Western Blot, Control, Staining, Small Interfering RNA

    VEGFB stimulated the differentiation of C2C12 cells via VEGFRs signaling. ( A ) Effect of 100 ng/mL of VEGFB and/or Axitinib on the differentiation of C2C12 after 5 days of differentiation was determined by immunofluorescence of MyHC ( n = 3). The nuclei were stained with Hoechst, and the scale bar = 200 µm. ( B ) The differentiation index was counted by comparing the MyHC-positive cells to total nuclei. ( C ) Western blot analysis of MyHC, MyoD, and MyoG in C2C12 after 5 days of differentiation. β-Actin was used as loading control. ( D ) Mean ± SEM of immunoblotting bands of MyHC, MyoD, and MyoG; the results are expressed as arbitrary units ( n = 6). * p < 0.05 versus control group. n.s = not significant.

    Journal: International Journal of Molecular Sciences

    Article Title: VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway

    doi: 10.3390/ijms222413352

    Figure Lengend Snippet: VEGFB stimulated the differentiation of C2C12 cells via VEGFRs signaling. ( A ) Effect of 100 ng/mL of VEGFB and/or Axitinib on the differentiation of C2C12 after 5 days of differentiation was determined by immunofluorescence of MyHC ( n = 3). The nuclei were stained with Hoechst, and the scale bar = 200 µm. ( B ) The differentiation index was counted by comparing the MyHC-positive cells to total nuclei. ( C ) Western blot analysis of MyHC, MyoD, and MyoG in C2C12 after 5 days of differentiation. β-Actin was used as loading control. ( D ) Mean ± SEM of immunoblotting bands of MyHC, MyoD, and MyoG; the results are expressed as arbitrary units ( n = 6). * p < 0.05 versus control group. n.s = not significant.

    Article Snippet: Recombinant mouse VEGFB protein (#293-VE-010) was purchased from R&D systems (Minneapolis, MN, USA).

    Techniques: Immunofluorescence, Staining, Western Blot, Control

    Knockdown of VEGFR1, rather than NRP1, was involved in VEGFB-promoted differentiation of C2C12 cells. ( A ) Western blot analysis of VEGFR1 and NRP1 in C2C12 after 5 days of differentiation. β-Actin was used as loading control. ( B ) Mean ± SEM of immunoblotting bands of VEGFR1 and NRP1; the results are expressed as arbitrary units ( n = 6). ( C ) Effect of 100 ng/mL of VEGFB and/or siVEGFR1 on the differentiation of C2C12 after 5 days of differentiation was determined by immunofluorescence of MyHC ( n = 3). The nuclei were stained with Hoechst, and the scale bar = 200 µm. ( D ) The differentiation index was counted by comparing the MyHC-positive cells to total nuclei in panel C. ( E ) Western blot analysis of MyHC, MyoD, and MyoG in C2C12 after 5 days of differentiation. β-Tubulin was used as loading control. ( F ) Mean ± SEM of immunoblotting bands of MyHC, MyoD, and MyoG; the results are expressed as arbitrary units ( n = 3). ( G ) Effect of 100 ng/mL of VEGFB and/or siNRP1 on the differentiation of C2C12 after 5 days of differentiation was determined by immunofluorescence of MyHC ( n = 3). Scale bar = 200 µm ( H ) The differentiation index was counted by comparing the MyHC-positive cells to total nuclei in panel G. The nuclei were stained with Hoechst; * p < 0.05 versus control group. # p < 0.05 versus the siNRP1 group. n.s = not significant. siVEGFR1 and siNRP1, small interfering RNA for VEGFR1 and NRP1, respectively.

    Journal: International Journal of Molecular Sciences

    Article Title: VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway

    doi: 10.3390/ijms222413352

    Figure Lengend Snippet: Knockdown of VEGFR1, rather than NRP1, was involved in VEGFB-promoted differentiation of C2C12 cells. ( A ) Western blot analysis of VEGFR1 and NRP1 in C2C12 after 5 days of differentiation. β-Actin was used as loading control. ( B ) Mean ± SEM of immunoblotting bands of VEGFR1 and NRP1; the results are expressed as arbitrary units ( n = 6). ( C ) Effect of 100 ng/mL of VEGFB and/or siVEGFR1 on the differentiation of C2C12 after 5 days of differentiation was determined by immunofluorescence of MyHC ( n = 3). The nuclei were stained with Hoechst, and the scale bar = 200 µm. ( D ) The differentiation index was counted by comparing the MyHC-positive cells to total nuclei in panel C. ( E ) Western blot analysis of MyHC, MyoD, and MyoG in C2C12 after 5 days of differentiation. β-Tubulin was used as loading control. ( F ) Mean ± SEM of immunoblotting bands of MyHC, MyoD, and MyoG; the results are expressed as arbitrary units ( n = 3). ( G ) Effect of 100 ng/mL of VEGFB and/or siNRP1 on the differentiation of C2C12 after 5 days of differentiation was determined by immunofluorescence of MyHC ( n = 3). Scale bar = 200 µm ( H ) The differentiation index was counted by comparing the MyHC-positive cells to total nuclei in panel G. The nuclei were stained with Hoechst; * p < 0.05 versus control group. # p < 0.05 versus the siNRP1 group. n.s = not significant. siVEGFR1 and siNRP1, small interfering RNA for VEGFR1 and NRP1, respectively.

    Article Snippet: Recombinant mouse VEGFB protein (#293-VE-010) was purchased from R&D systems (Minneapolis, MN, USA).

    Techniques: Knockdown, Western Blot, Control, Immunofluorescence, Staining, Small Interfering RNA

    VEGFB activated the PI3K/Akt/mTOR signaling pathway in a VEGFR1-dependent manner and the inhibition of PI3K/Akt blocked the promotion of C2C12 differentiation induced by VEGFB. ( A ) Western blot analysis of p-PI3K, PI3K, p-Akt, Akt p-mTOR, mTOR, p-S6, and S6 in C2C12 treated with or without VEGFB and/or axitinib after 5 days of differentiation. ( B ) Mean ± SEM of immunoblotting bands of p-PI3K/PI3K, p-Akt/Akt p-mTOR/mTOR, and p-S6/S6 in panel A. ( C ) Western blot analysis of p-PI3K, PI3K, p-Akt, Akt p-mTOR, mTOR, p-S6, and S6 in C2C12 treated with or without VEGFB and/or siVEGFR1 after 5 days of differentiation. ( D ) Mean ± SEM of immunoblotting bands of p-PI3K/PI3K, p-Akt/Akt, p-mTOR/mTOR, and p-S6/S6 in panel C; the results are expressed as arbitrary units ( n = 3). ( E ) Effect of 100 ng/mL of VEGFB and/or 2 µM of Wortmannin on the differentiation of C2C12 after 5 days of differentiation was determined by immunofluorescence of MyHC ( n = 3). The nuclei were stained with Hoechst and the scale bar = 200 µm. ( F ) The differentiation index was counted by comparing the MyHC-positive cells to total nuclei in panel E. ( G ) Western blot analysis of MyHC, MyoD, MyoG, p-PI3K/PI3K, p-Akt/Akt, p-mTOR/mTOR, and p-S6/S6 in C2C12 after 5 days of differentiation. GAPDH was used as loading control. ( H ) Mean ± SEM of immunoblotting bands of MyHC, MyoD, MyoG, p-PI3K/PI3K, p-Akt/Akt, p-mTOR/mTOR, and p-S6/S6; the results are expressed as arbitrary units ( n = 3). * p < 0.05 versus control group. n.s = not significant. siVEGFR1, small interfering RNA for VEGFR1.

    Journal: International Journal of Molecular Sciences

    Article Title: VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway

    doi: 10.3390/ijms222413352

    Figure Lengend Snippet: VEGFB activated the PI3K/Akt/mTOR signaling pathway in a VEGFR1-dependent manner and the inhibition of PI3K/Akt blocked the promotion of C2C12 differentiation induced by VEGFB. ( A ) Western blot analysis of p-PI3K, PI3K, p-Akt, Akt p-mTOR, mTOR, p-S6, and S6 in C2C12 treated with or without VEGFB and/or axitinib after 5 days of differentiation. ( B ) Mean ± SEM of immunoblotting bands of p-PI3K/PI3K, p-Akt/Akt p-mTOR/mTOR, and p-S6/S6 in panel A. ( C ) Western blot analysis of p-PI3K, PI3K, p-Akt, Akt p-mTOR, mTOR, p-S6, and S6 in C2C12 treated with or without VEGFB and/or siVEGFR1 after 5 days of differentiation. ( D ) Mean ± SEM of immunoblotting bands of p-PI3K/PI3K, p-Akt/Akt, p-mTOR/mTOR, and p-S6/S6 in panel C; the results are expressed as arbitrary units ( n = 3). ( E ) Effect of 100 ng/mL of VEGFB and/or 2 µM of Wortmannin on the differentiation of C2C12 after 5 days of differentiation was determined by immunofluorescence of MyHC ( n = 3). The nuclei were stained with Hoechst and the scale bar = 200 µm. ( F ) The differentiation index was counted by comparing the MyHC-positive cells to total nuclei in panel E. ( G ) Western blot analysis of MyHC, MyoD, MyoG, p-PI3K/PI3K, p-Akt/Akt, p-mTOR/mTOR, and p-S6/S6 in C2C12 after 5 days of differentiation. GAPDH was used as loading control. ( H ) Mean ± SEM of immunoblotting bands of MyHC, MyoD, MyoG, p-PI3K/PI3K, p-Akt/Akt, p-mTOR/mTOR, and p-S6/S6; the results are expressed as arbitrary units ( n = 3). * p < 0.05 versus control group. n.s = not significant. siVEGFR1, small interfering RNA for VEGFR1.

    Article Snippet: Recombinant mouse VEGFB protein (#293-VE-010) was purchased from R&D systems (Minneapolis, MN, USA).

    Techniques: Inhibition, Western Blot, Immunofluorescence, Staining, Control, Small Interfering RNA

    Proposed signaling pathways for VEGFB to promote C2C12 myoblasts proliferation and differentiation.

    Journal: International Journal of Molecular Sciences

    Article Title: VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway

    doi: 10.3390/ijms222413352

    Figure Lengend Snippet: Proposed signaling pathways for VEGFB to promote C2C12 myoblasts proliferation and differentiation.

    Article Snippet: Recombinant mouse VEGFB protein (#293-VE-010) was purchased from R&D systems (Minneapolis, MN, USA).

    Techniques: Protein-Protein interactions